These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 31970428)

  • 1. Clinical implications of intratumor heterogeneity: challenges and opportunities.
    Ramón Y Cajal S; Sesé M; Capdevila C; Aasen T; De Mattos-Arruda L; Diaz-Cano SJ; Hernández-Losa J; Castellví J
    J Mol Med (Berl); 2020 Feb; 98(2):161-177. PubMed ID: 31970428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
    Biswas A; De S
    Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in the Solid Cancer Cell Population and Its Consequences for Cancer Diagnostics and Treatment.
    Brychtová V; Valík V; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):5-13. PubMed ID: 31023018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumor heterogeneity in epigenetic patterns.
    Assenov Y; Brocks D; Gerhäuser C
    Semin Cancer Biol; 2018 Aug; 51():12-21. PubMed ID: 29366906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence.
    Vessoni AT; Filippi-Chiela EC; Lenz G; Batista LFZ
    Oncogene; 2020 Mar; 39(10):2055-2068. PubMed ID: 31801972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-driven intratumor heterogeneity and immune evasion.
    Terry S; Engelsen AST; Buart S; Elsayed WS; Venkatesh GH; Chouaib S
    Cancer Lett; 2020 Nov; 492():1-10. PubMed ID: 32712233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
    Gerlinger M; Rowan AJ; Horswell S; Math M; Larkin J; Endesfelder D; Gronroos E; Martinez P; Matthews N; Stewart A; Tarpey P; Varela I; Phillimore B; Begum S; McDonald NQ; Butler A; Jones D; Raine K; Latimer C; Santos CR; Nohadani M; Eklund AC; Spencer-Dene B; Clark G; Pickering L; Stamp G; Gore M; Szallasi Z; Downward J; Futreal PA; Swanton C
    N Engl J Med; 2012 Mar; 366(10):883-892. PubMed ID: 22397650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal cooperativity in heterogenous cancers.
    Zhou H; Neelakantan D; Ford HL
    Semin Cell Dev Biol; 2017 Apr; 64():79-89. PubMed ID: 27582427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics.
    Stanta G; Bonin S
    Pathobiology; 2018; 85(1-2):7-17. PubMed ID: 28750401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity and cancer.
    Allison KH; Sledge GW
    Oncology (Williston Park); 2014 Sep; 28(9):772-8. PubMed ID: 25224475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution.
    Gupta RG; Somer RA
    Mol Cancer Res; 2017 Sep; 15(9):1127-1137. PubMed ID: 28596419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumor heterogeneity: nature and biological significance.
    Gerashchenko TS; Denisov EV; Litviakov NV; Zavyalova MV; Vtorushin SV; Tsyganov MM; Perelmuter VM; Cherdyntseva NV
    Biochemistry (Mosc); 2013 Nov; 78(11):1201-15. PubMed ID: 24460935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design.
    Diaz-Cano SJ
    Int J Mol Sci; 2012; 13(2):1951-2011. PubMed ID: 22408433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-tumour heterogeneity: a looking glass for cancer?
    Marusyk A; Almendro V; Polyak K
    Nat Rev Cancer; 2012 Apr; 12(5):323-34. PubMed ID: 22513401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer intratumor genetic heterogeneity: causes and implications.
    Ng CK; Pemberton HN; Reis-Filho JS
    Expert Rev Anticancer Ther; 2012 Aug; 12(8):1021-32. PubMed ID: 23030222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of phenotypic plasticity leads to tumor heterogeneity with implications for therapy.
    Syga S; Jain HP; Krellner M; Hatzikirou H; Deutsch A
    PLoS Comput Biol; 2024 Aug; 20(8):e1012003. PubMed ID: 39121170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Models of oncogenesis: an endless world?].
    Larsen CJ
    Bull Cancer; 2013 Jun; 100(6):555-60. PubMed ID: 23719507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging Single-Cell Approaches in Cancer Precision Medicine.
    Nath A; Bild AH
    Trends Cancer; 2021 Apr; 7(4):359-372. PubMed ID: 33563578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.